Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Mobile App-Controlled Patch Reduces Migraine Pain

A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines. . . . → Read More: Mobile App-Controlled Patch Reduces Migraine Pain

Trial Begins Testing Enhanced Cord Blood Stem Cells

A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient. . . . → Read More: Trial Begins Testing Enhanced Cord Blood Stem Cells

Smart Watch Software Designed to Verify Signatures

Engineering researchers in Israel created software that enables smart watches and fitness bands to capture wrist movements for verifying a person’s signature. . . . → Read More: Smart Watch Software Designed to Verify Signatures

Precision Health Tech Network Expands, Invests $400M

Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network. . . . → Read More: Precision Health Tech Network Expands, Invests $400M

Crowdfunded Digital Health Investment Fund Launches

An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies. . . . → Read More: Crowdfunded Digital Health Investment Fund Launches

Teva Licenses Pain Relief Antibody for $1.25 Billion

Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion

Stem Cell Treatments Show Benefit for ALS Patients

A clinical trial testing the safety of treatments derived from patients’ stem cells shows patients with ALS were able to slow the progression of their disease. . . . → Read More: Stem Cell Treatments Show Benefit for ALS Patients

Antibody Treatment Shown to Prevent Migraine

(geralt, Pixabay)

9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology.

Migraine . . . → Read More: Antibody Treatment Shown to Prevent Migraine

Venture Firm Funding Univ. Blood Diagnostics Technology

(Public Domain Pictures/Pixabay)

23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, . . . → Read More: Venture Firm Funding Univ. Blood Diagnostics Technology

ReWalk, Wyss Institute Developing Soft Exoskeleton Robot

Robotic exosuit being tested (Biodesign Lab, Harvard University)

17 May 2016. A robotics company is licensing technology from a bioengineering lab at Harvard University to develop systems for people needing help with mobility, such as those with multiple sclerosis or suffering a stroke. Financial aspects of the deal between ReWalk Robotics Ltd. in Yokneam . . . → Read More: ReWalk, Wyss Institute Developing Soft Exoskeleton Robot